Innate Pharma SA
For the period ended Aug 19, 2026. Filed Aug 19, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Aug 19, 2026 · Filed Aug 19, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · 7.7 Partial Unenforceability
7.7 Partial Unenforceability
The invalidity or unenforceability of any section, paragraph or provision of this Agreement shall not affect the validity or enforceability of any other section, paragraph or provision hereof. If any section, paragraph or provision of this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and only such minor changes) as are necessary to make it valid and enforceable.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.